These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1825 related items for PubMed ID: 23140544

  • 1. The clinical effectiveness and cost-effectiveness of primary stroke prevention in children with sickle cell disease: a systematic review and economic evaluation.
    Cherry MG, Greenhalgh J, Osipenko L, Venkatachalam M, Boland A, Dundar Y, Marsh K, Dickson R, Rees DC.
    Health Technol Assess; 2012; 16(43):1-129. PubMed ID: 23140544
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial.
    Ware RE, Davis BR, Schultz WH, Brown RC, Aygun B, Sarnaik S, Odame I, Fuh B, George A, Owen W, Luchtman-Jones L, Rogers ZR, Hilliard L, Gauger C, Piccone C, Lee MT, Kwiatkowski JL, Jackson S, Miller ST, Roberts C, Heeney MM, Kalfa TA, Nelson S, Imran H, Nottage K, Alvarez O, Rhodes M, Thompson AA, Rothman JA, Helton KJ, Roberts D, Coleman J, Bonner MJ, Kutlar A, Patel N, Wood J, Piller L, Wei P, Luden J, Mortier NA, Stuber SE, Luban NLC, Cohen AR, Pressel S, Adams RJ.
    Lancet; 2016 Feb 13; 387(10019):661-670. PubMed ID: 26670617
    [Abstract] [Full Text] [Related]

  • 6. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
    Estcourt LJ, Fortin PM, Hopewell S, Trivella M, Wang WC.
    Cochrane Database Syst Rev; 2017 Jan 17; 1(1):CD003146. PubMed ID: 28094851
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
    Wang WC, Dwan K.
    Cochrane Database Syst Rev; 2013 Nov 14; (11):CD003146. PubMed ID: 24226646
    [Abstract] [Full Text] [Related]

  • 9. Big strokes in small persons.
    Adams RJ.
    Arch Neurol; 2007 Nov 14; 64(11):1567-74. PubMed ID: 17998439
    [Abstract] [Full Text] [Related]

  • 10. Testing strategies for Lynch syndrome in people with endometrial cancer: systematic reviews and economic evaluation.
    Stinton C, Jordan M, Fraser H, Auguste P, Court R, Al-Khudairy L, Madan J, Grammatopoulos D, Taylor-Phillips S.
    Health Technol Assess; 2021 Jun 14; 25(42):1-216. PubMed ID: 34169821
    [Abstract] [Full Text] [Related]

  • 11. Rapid antigen detection and molecular tests for group A streptococcal infections for acute sore throat: systematic reviews and economic evaluation.
    Fraser H, Gallacher D, Achana F, Court R, Taylor-Phillips S, Nduka C, Stinton C, Willans R, Gill P, Mistry H.
    Health Technol Assess; 2020 Jun 14; 24(31):1-232. PubMed ID: 32605705
    [Abstract] [Full Text] [Related]

  • 12. Systematic review and modelling of the cost-effectiveness of cardiac magnetic resonance imaging compared with current existing testing pathways in ischaemic cardiomyopathy.
    Campbell F, Thokala P, Uttley LC, Sutton A, Sutton AJ, Al-Mohammad A, Thomas SM.
    Health Technol Assess; 2014 Sep 14; 18(59):1-120. PubMed ID: 25265259
    [Abstract] [Full Text] [Related]

  • 13. Clinical effectiveness and cost-effectiveness of second- and third-generation left ventricular assist devices as either bridge to transplant or alternative to transplant for adults eligible for heart transplantation: systematic review and cost-effectiveness model.
    Sutcliffe P, Connock M, Pulikottil-Jacob R, Kandala NB, Suri G, Gurung T, Grove A, Shyangdan D, Briscoe S, Maheswaran H, Clarke A.
    Health Technol Assess; 2013 Nov 14; 17(53):1-499, v-vi. PubMed ID: 24280231
    [Abstract] [Full Text] [Related]

  • 14. Hydroxyurea (hydroxycarbamide) for sickle cell disease.
    Rankine-Mullings AE, Nevitt SJ.
    Cochrane Database Syst Rev; 2022 Sep 01; 9(9):CD002202. PubMed ID: 36047926
    [Abstract] [Full Text] [Related]

  • 15. Hydroxyurea (hydroxycarbamide) for sickle cell disease.
    Nevitt SJ, Jones AP, Howard J.
    Cochrane Database Syst Rev; 2017 Apr 20; 4(4):CD002202. PubMed ID: 28426137
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Implementation of transcranial Doppler ultrasonography screening and primary stroke prevention in urban and rural sickle cell disease populations.
    Hussain S, Nichols F, Bowman L, Xu H, Neunert C.
    Pediatr Blood Cancer; 2015 Feb 20; 62(2):219-223. PubMed ID: 25381872
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 92.